• Protein A/G Magnetic Co-IP/IP Kit: Mechanistic Guide

  2026-08-29

  Discover how the Protein A/G Magnetic Co-IP/IP Kit supports rigorous protein-protein interaction analysis, using the RNF8–DAPK1 axis in ischemic-stroke research as a model for assay design, controls, and interpretation.

• Azilsartan Medoxomil Monopotassium Workflows

  2026-08-28

  Build reproducible AT1-receptor, cellular, and preclinical blood-pressure workflows with Azilsartan medoxomil monopotassium (TAK 491). The guide connects formulation control, sustained-binding experiments, and translational study design while separating assay recommendations from clinical evidence.

• Network Medicine Identifies Apigenin in Alzheimer’s

  2026-08-28

  A 2025 study used network medicine to screen flavonoids by their proximity to Alzheimer’s disease targets, prioritizing 48 candidates and identifying apigenin as the leading compound. Integrated network analysis and cell-based validation linked apigenin to mitochondrial protection, apoptosis suppression, AKT/NF-κB regulation, and microglial polarization, while also highlighting important limits for translation.

• Anlotinib hydrochloride in Angiogenesis Assays

  2026-08-27

  Anlotinib hydrochloride gives researchers a practical way to connect endothelial migration, tube formation, receptor phosphorylation, and tumor angiogenesis in one workflow. Its multi-target profile supports mechanism-driven cancer research while its low cytotoxicity at functional concentrations helps distinguish pathway inhibition from nonspecific cell loss.

• Lysis Buffer for Decision-Ready Mouse Genotyping

  2026-08-27

  Discover how lysis buffer chemistry supports genomic DNA release from mouse tail tissue and improves decision-ready mouse genotyping. This article connects pre-analytical DNA quality, assay controls, and translational model interpretation without confusing genotype confirmation with cancer biomarker profiling.

• ZIF8 Nanotheranostics for TNBC: Study Insights

  2026-08-26

  Li et al. developed FA-PEG@ZIF8@CIP, a folate-targeted, pH-responsive nanoplatform that combines ultrasound imaging with ciprofloxacin-based sonodynamic therapy, chemotherapy, and immune activation. The study links ultrasound-enhanced ROS production to immunogenic cell death, dendritic-cell maturation, and increased CD8+ T-cell infiltration, while identifying important control and translation requirements for future validation.

• Alternariol (AOH) for Reliable Cell Assays

  2026-08-26

  Alternariol (AOH), SKU C5061, provides a chemically defined research reagent for investigating cell viability, cytoskeletal effects, apoptosis, and mycotoxin-associated hepatic responses. This scenario-based guide explains stock preparation, assay controls, endpoint interpretation, and practical supplier-selection criteria for more defensible laboratory workflows.

• Birinapant (TL32711) and the Apoptosis Decision

  2026-08-25

  Birinapant (TL32711) offers a mechanistically focused way to interrogate IAP-dependent apoptosis resistance. When paired with the MDM1–p53 findings in colorectal cancer, it supports a biomarker-led framework for studying TNF and TRAIL signaling, caspase activation, and chemoradiotherapy sensitization—while keeping the distinction between established evidence and translational hypothesis explicit.

• Annexin V-Cy5/DAPI Apoptosis Kit for Ph+ ALL

  2026-08-25

  Translate PS exposure and membrane integrity into a rapid, two-parameter readout for TKI-treated leukemia cells. This apoptosis detection kit supports both flow cytometry and fluorescence microscopy, making it useful for connecting P2RX1-driven mitochondrial stress with functional cell-death outcomes.

• CDK9 inhibitor (A3294): Lab Workflow Guide

  2026-08-24

  CDK9 inhibitor (A3294) is a selective serine/threonine kinase inhibitor for studying CDK9-dependent transcription elongation and HIV-1 propagation inhibition without treating the compound as a general cytotoxic agent. It is suitable for focused biochemical and cellular pathway experiments, but not for pan-CDK inhibition, broad cell-cycle regulation studies, or protocols that require long-term storage of prepared solutions.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Assay Guide

  2026-08-24

  Learn how EZ Cap™ Cy5 EGFP mRNA (5-moUTP), SKU R1011, can separate mRNA uptake from functional translation in viability, proliferation, cytotoxicity, and nanoparticle studies. This scenario-based guide covers assay design, handling, interpretation, and practical vendor-selection criteria.

• p-Cresyl sulfate Workflows for CKD Research

  2026-08-23

  Build reproducible p-Cresyl sulfate models for endothelial dysfunction, valvular calcification, and uremic toxin clearance research. This guide connects concentration-controlled cell assays with albumin-aware interpretation, fresh-solution handling, and mechanistic validation through the klotho/SIRT1 axis.

• Griseofulvin: From Spindle Poison to Assay Logic

  2026-08-22

  Griseofulvin is a microtubule associated inhibitor with value beyond routine antifungal testing. This article develops a mechanism-first strategy that connects fungal mitosis phenotypes with modern aneugenicity assay logic while defining the limits of that comparison.

• Leptin (116-130), amide, mouse: Translational Strategy

  2026-08-21

  A thought-leadership perspective on how Leptin (116-130), amide, mouse can connect energy homeostasis regulation with immunometabolic and cardiovascular research while keeping mechanistic claims, assay design, and translational limits clearly defined.

• Palmitic acid: Protocol and QC Guide

  2026-08-20

  Palmitic acid (hexadecanoic acid, SKU N2456) provides a defined saturated long-chain fatty acid for lipid metabolism, insulin signaling, inflammation, and protein palmitoylation workflows. It is unsuitable for aqueous stock preparation and long-term solution storage, so solvent selection, matched vehicle controls, and prompt use are central to reproducible assays.

7951 records 1/531 page Next 12345 下5页 Last page